Natural Killer T cells and the invariant subset promote atherosclerosis: A meta-analysis

Rituparna Chakrabarti1, Sushmitha Duddu1, Ashutosh Tiwari2

  • 1School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, WB, India.

Life Sciences
|April 3, 2023
PubMed
Abstract

Insights

Natural Killer T (NKT) cells and their subsets promote atherosclerosis. NKT cell numbers increase with plaque progression, while iNKT cells decrease in established disease in mice and humans.

Area of Science:

  • Immunology
  • Cardiovascular Research
  • Atherosclerosis Research

Background:

  • The role of Natural Killer T (NKT) cells in atherosclerosis is debated, with evidence suggesting both pro- and anti-atherosclerotic effects.
  • Understanding the specific contributions of NKT cell populations and their subsets is crucial for developing targeted therapies.

Approach:

  • This meta-analysis synthesized data from 18 pre-clinical mouse studies (n=1276) and 6 human observational studies (n=116).
  • Random effects models were employed to calculate the standard mean difference (SMD) for cell counts and aortic lesion area.

Key Points:

  • Absence of whole NKT cells or iNKT subsets reduced lesion area, while iNKT overexpression/activation increased it.
  • Atherogenic diets increased total NKT cell counts.
  • iNKT cell numbers and gene expression decreased in advanced disease stages in both mice and humans.

Conclusions:

  • NKT cells and specifically iNKT cells appear to promote atherosclerosis development and progression.
  • NKT cell populations generally increase with plaque growth, whereas iNKT cell numbers decline as the disease becomes established.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
21
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.8K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Inflammation01:38

Inflammation

Overview
54.2K